Patent ID: 6610692
Filing Date: 2003-08-26
Classification: A61P,C07D

Abstract:
A compound of the formula or a pharmaceutically acceptable salt thereof, whereinb is NY1 or O; c is CY2 or N; d is CY3 or N; e is CY4 or N; f is CY5 or N; g is CY6 or N, provided that 1) when e and f are N, g is CY6, 2) when e and g are N, f is CY5, and 3) when f and g are N, e is CY4; Y1, Y2, Y3, Y4, Y5, and Y6 are independently selected from the group consisting of hydrogen, C1-4 alkyl, NH2 and Cl; A is X is selected from the group consisting of hydrogen and halogen; R3 is selected from the group consisting of hydrogen and C1-4 alkyl; W is selected from the group consisting of hydrogen, R2, R2SO2, R2CH2SO2, and â€ƒwhere m is 0-3, and R2 is selected from the group consisting of hydrogen, C1-7 alkyl unsubstituted or substituted with phenyl, naphthyl or C3-7 cycloalkyl.